Pharma minutes

Tuesday, 20 February 2018

Labels: Job

Creador to invest Rs 118 crore in Corona Remedies

Private equity firm Creador plans to invest Rs 118 crore in pharmaceutical firm Corona Remedies. Cydista Ltd, an affiliate of Creador III ...
Drug overcharging case: Supreme Court directs Cipla to pay Rs 175.07 crore

Cipla has been asked by the Supreme Court to deposit Rs 175.07 crore with regard to cases pertaining to overcharging of certain drugs, t...
Roche, Biocon clash accusing contempt of court

The ongoing battle between Swiss drug maker Roche and Bangalore-based biotech major Biocon over breast cancer drug trastuzumab has taken ...
Valeant Pharma gets US FDA CRL for latanoprostene bunod ophthalmic solution 0.024% NDA

Valeant Pharmaceuticals International, Inc. has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) re...
The ESO and Boehringer launch the "Angels Initiative"

Suffering a stroke is one of the most devastating medical emergencies that can happen to a person. It is also a great challenge for the med...

Simple theme. Powered by Blogger.